|
[1]
|
Chen NS, Zhou M, Dong X, Qu JM, Gong FY, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507 − 13. http://dx.doi.org/10.1016/S0140-6736(20)30211-7CrossRef
|
|
[2]
|
Fu LW, Wang BY, Yuan TW, Chen XT, Ao YL, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 2020;80(6):656 − 65. http://dx.doi.org/10.1016/j.jinf.2020.03.041CrossRef
|
|
[3]
|
Wu ZY, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323(13):1239 − 42. http://dx.doi.org/10.1001/jama.2020.2648CrossRef
|
|
[4]
|
Liu H, Chen SY, Liu M, Nie H, Lu HY. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis 2020;11(3):668 − 78. http://dx.doi.org/10.14336/ad.2020.0502CrossRef
|
|
[5]
|
National Health Commission of the People's Republic of China. Press Conference of the State Council's Joint Prevention and Control Mechanism on January 14, 2023, Introducing the Relevant Situation of Health Protection for Key Populations. 2023. http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11507&gecstype=1. [2023-3-4]. (In Chinese). http://www.nhc.gov.cn/xwzb/webcontroller.do?titleSeq=11507&gecstype=1 |
|
[6]
|
Sanyaolu A, Marinkovic A, Prakash S, Zhao A, Balendra V, Haider N, et al. Post-acute sequelae in COVID-19 survivors: an overview. SN Compr Clin Med 2022;4(1):91. http://dx.doi.org/10.1007/s42399-022-01172-7CrossRef
|
|
[7]
|
Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 2022;399(10343):2263 − 4. http://dx.doi.org/10.1016/S0140-6736(22)00941-2CrossRef
|
|
[8]
|
Magson NR, Freeman JYA, Rapee RM, Richardson CE, Oar EL, Fardouly J. Risk and protective factors for prospective changes in adolescent mental health during the COVID-19 pandemic. J Youth Adolesc 2021;50(1):44 − 57. http://dx.doi.org/10.1007/s10964-020-01332-9CrossRef
|
|
[9]
|
Marks PW, Gruppuso PA, Adashi EY. Urgent need for next-generation COVID-19 vaccines. JAMA 2023;329(1):19 − 20. http://dx.doi.org/10.1001/jama.2022.22759CrossRef
|
|
[10]
|
Nordström P, Ballin M, Nordström A. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Lancet Infect Dis 2022;22(6):781 − 90. http://dx.doi.org/10.1016/S1473-3099(22)00143-8CrossRef
|
|
[11]
|
Rose GL, Bonnell LN, Clifton J, Natkin LW, Hitt JR, O’Rourke-Lavoie J. Outcomes of delay of care after the onset of COVID-19 for patients managing multiple chronic conditions. J Am Board Fam Med 2022;35(6):1081 − 91. http://dx.doi.org/10.3122/jabfm.2022.220112R1CrossRef
|
|
[12]
|
Crook H, Raza S, Nowell J, Young M, Edison P. Long covid—mechanisms, risk factors, and management. BMJ 2021;374:n1648. http://dx.doi.org/10.1136/bmj.n1648CrossRef
|
|
[13]
|
Centers for Disease Control and Prevention. COVID data tracker. 2023. https://covid.cdc.gov/covid-data-tracker. [2023-2-23].https://covid.cdc.gov/covid-data-tracker |
|
[14]
|
Mitha S. U. K. COVID-19 diary: policy and impacts. Natl Tax J 2020;73(3):847 − 78. http://dx.doi.org/10.17310/ntj.2020.3.10CrossRef
|
|
[15]
|
Cabinet Office, Government of Japan. Measures to prevent the spread of COVID-19. 2023. https://corona.go.jp/en/. [2023-3-4].https://corona.go.jp/en/ |